GT1b ganglioside (GT1b)

GT1b ganglioside is a complex glycosphingolipid containing three sialic acid residues, predominantly localized within the neuronal membranes of the central and peripheral nervous systems (PubChem CID 11954225). It serves as a critical component in maintaining neuronal stability and modulating signal transduction pathways, including those involving nerve growth factors (Yamashita et al., 2005). GT1b is notably recognized as a primary receptor for potent bacterial neurotoxins such as Botulinum and Tetanus toxins, which exploit the ganglioside to gain entry into nerve cells (Rummel et al., 2004; PMID: 15591140). In the context of human pathology, GT1b is a significant autoantigen; the presence of anti-GT1b antibodies is a diagnostic hallmark of certain variants of Guillain-Barré syndrome, such as Miller Fisher syndrome (Koga et al., 2001; PMID: 11709235). Furthermore, GT1b has been implicated in the regulation of axonal regeneration and the aggregation of amyloid-beta in Alzheimer's disease, making it a subject of interest for neuroprotective and regenerative therapies (Yanagisawa et al., 1995; PMID: 7585147).

Other names

Trisialoganglioside GT1bII3Neu5Ac,IV3(Neu5Ac)2-Gg4CerGanglioside GT1b

GT1b acts as a high-affinity binding site for bacterial neurotoxins, facilitating their internalization into neurons. In autoimmune conditions, it serves as an antigen for autoantibodies, leading to complement-mediated nerve damage. It also interacts with myelin-associated glycoprotein (MAG) to inhibit axonal regeneration.